Which route bypasses first-pass metabolism and can provide rapid onset?

Which route bypasses first-pass metabolism and can provide rapid onset?

• A. Sublingual route.
• B. Oral ingestion.
• C. Intramuscular injection.
• D. Transdermal patch.

Answer: (A)

Some drugs are absorbed in a way that avoids the liver’s first-pass metabolism, so they reach the bloodstream quickly and start working sooner. The sublingual route fits this best because the tissue under the tongue is highly vascular, allowing fast absorption directly into the systemic circulation. The blood from these vessels goes to the heart and rest of the body without passing through the liver first, so enzymes that would normally metabolize the drug right away don’t have the chance to act. This combination—rapid entry into circulation and avoidance of hepatic first-pass—produces a quick onset of action and often higher bioavailability for drugs that are heavily metabolized if swallowed. Oral ingestion, by contrast, passes through the digestive system and then through the liver before reaching systemic circulation, which can slow onset and reduce the amount that acts quickly. Transdermal patches deliver drugs slowly through the skin, giving gradual, sustained effects rather than rapid onset. Intramuscular injection does bypass first-pass metabolism, but the key point here is the rapid onset achieved efficiently via the sublingual route, especially for drugs that would be heavily metabolized if swallowed.

Some drugs are absorbed in a way that avoids the liver’s first-pass metabolism, so they reach the bloodstream quickly and start working sooner. The sublingual route fits this best because the tissue under the tongue is highly vascular, allowing fast absorption directly into the systemic circulation. The blood from these vessels goes to the heart and rest of the body without passing through the liver first, so enzymes that would normally metabolize the drug right away don’t have the chance to act. This combination—rapid entry into circulation and avoidance of hepatic first-pass—produces a quick onset of action and often higher bioavailability for drugs that are heavily metabolized if swallowed.

Oral ingestion, by contrast, passes through the digestive system and then through the liver before reaching systemic circulation, which can slow onset and reduce the amount that acts quickly. Transdermal patches deliver drugs slowly through the skin, giving gradual, sustained effects rather than rapid onset. Intramuscular injection does bypass first-pass metabolism, but the key point here is the rapid onset achieved efficiently via the sublingual route, especially for drugs that would be heavily metabolized if swallowed.